DISCOVERY EXPOSOMICS Trademark

Trademark Overview


On Friday, February 13, 2026, a trademark application was filed for DISCOVERY EXPOSOMICS with the United States Patent and Trademark Office. The USPTO has given the DISCOVERY EXPOSOMICS trademark a serial number of 99651376. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, July 6, 2026. This trademark is owned by Panome Bio Inc.. The DISCOVERY EXPOSOMICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the fields of metabolomics, multi-omics, proteomics, transcriptomics, lipidomics, chemical exposure analysis, post-translational modification analysis, and biomarker identification; technical consultancy in the field of scientific research relating to metabolomics, multi-omics, proteomics, transcriptomics, lipidomics, chemical exposure analysis, post-translational modification analysis, and biomarker identification; research and development in the fields of metabolomics, multi-omics, proteomics, transcriptomics, lipidomics, chemical exposure analysis, post-translational modification analysis, and biomarker identification; conducting scientific studies in the fields of metabolomics, multi-omics, proteomics, transcriptomics, lipidomics, chemical exposure analysis, post-translational modification analysis, and biomarker identification

General Information


Serial Number99651376
Word MarkDISCOVERY EXPOSOMICS
Filing DateFriday, February 13, 2026
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, July 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


NOT AVAILABLEEXPOSOMICS
Goods and ServicesScientific research in the fields of metabolomics, multi-omics, proteomics, transcriptomics, lipidomics, chemical exposure analysis, post-translational modification analysis, and biomarker identification; technical consultancy in the field of scientific research relating to metabolomics, multi-omics, proteomics, transcriptomics, lipidomics, chemical exposure analysis, post-translational modification analysis, and biomarker identification; research and development in the fields of metabolomics, multi-omics, proteomics, transcriptomics, lipidomics, chemical exposure analysis, post-translational modification analysis, and biomarker identification; conducting scientific studies in the fields of metabolomics, multi-omics, proteomics, transcriptomics, lipidomics, chemical exposure analysis, post-translational modification analysis, and biomarker identification

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 13, 2026
Primary Code042
First Use Anywhere DateThursday, March 5, 2026
First Use In Commerce DateThursday, March 5, 2026

Trademark Owner History


Party NamePanome Bio Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63110
US

Trademark Events


Event DateEvent Description
Friday, February 13, 2026NEW APPLICATION ENTERED
Friday, February 13, 2026APPLICATION FILING RECEIPT MAILED
Thursday, June 11, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 12, 2026ASSIGNED TO EXAMINER
Friday, June 19, 2026NON-FINAL ACTION WRITTEN
Friday, June 19, 2026NON-FINAL ACTION E-MAILED
Friday, June 19, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 6, 2026TEAS AMENDMENT OF USE RECEIVED
Monday, July 6, 2026USE AMENDMENT FILED
Monday, July 6, 2026AMENDMENT TO USE PROCESSING COMPLETE
Monday, July 6, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 6, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 6, 2026TEAS/EMAIL CORRESPONDENCE ENTERED